Safety and efficacy of low‐dose fondaparinux (1.5 mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: the FONDAIR study

W. AGENO, N. RIVA, P. NORIS, M. DI NISIO, M. LA REGINA, D. ARIOLI, L. RIA, V. MONZANI, S. CUPPINI, E. LUPIA, M. GIORGI PIERFRANCESCHI, F. DENTALI

Open source

DOI
10.1111/j.1538-7836.2012.04908.x
Published
2012-11
Container
Journal of Thrombosis and Haemostasis
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/j.1538-7836.2012.04908.x,
  title = {Safety and efficacy of low‐dose fondaparinux (1.5 mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: the FONDAIR study},
  author = {W. AGENO and N. RIVA and P. NORIS and M. DI NISIO and M. LA REGINA and D. ARIOLI and L. RIA and V. MONZANI and S. CUPPINI and E. LUPIA and M. GIORGI PIERFRANCESCHI and F. DENTALI},
  year = {2012},
  journal = {Journal of Thrombosis and Haemostasis},
  doi = {10.1111/j.1538-7836.2012.04908.x},
  url = {https://doi.org/10.1111/j.1538-7836.2012.04908.x}
}

RIS

TY  - JOUR
TI  - Safety and efficacy of low‐dose fondaparinux (1.5 mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: the FONDAIR study
AU  - W. AGENO
AU  - N. RIVA
AU  - P. NORIS
AU  - M. DI NISIO
AU  - M. LA REGINA
AU  - D. ARIOLI
AU  - L. RIA
AU  - V. MONZANI
AU  - S. CUPPINI
AU  - E. LUPIA
AU  - M. GIORGI PIERFRANCESCHI
AU  - F. DENTALI
PY  - 2012
JO  - Journal of Thrombosis and Haemostasis
DO  - 10.1111/j.1538-7836.2012.04908.x
UR  - https://doi.org/10.1111/j.1538-7836.2012.04908.x
ER  - 

APA

AGENO, W., RIVA, N., NORIS, P., NISIO, M. D., REGINA, M. L., ARIOLI, D., RIA, L., MONZANI, V., CUPPINI, S., LUPIA, E., PIERFRANCESCHI, M. G., & DENTALI, F. (2012). Safety and efficacy of low‐dose fondaparinux (1.5 mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: the FONDAIR study. Journal of Thrombosis and Haemostasis. https://doi.org/10.1111/j.1538-7836.2012.04908.x

Source records